Nanomaterials: a brief review and regulatory considerations

Nanomaterials

Nanomaterials are defined as a natural, incidental or manufactured materials consisting of solid particles that are present, either on their own or as identifiable constituent particles in aggregates or agglomerates, and where 50 % or more of these particles in the number-based size distribution fulfil at least one of the following conditions[1],[2]: one or more […]

Companion Diagnostics: A Vital Component in Medical Device Advancements

Companion Diagnostics

In the rapidly evolving landscape of healthcare, precision medicine has emerged as a groundbreaking approach to tailor medical treatment to the individual characteristics of each patient. At the forefront of this revolution are companion diagnostics (CDx), an integral component of medical devices that holds the key to unlocking personalized and targeted therapies. Let’s explore the […]

Free From Claims: the assessor’s position

Free From Claims

In the realm of cosmetics, it is imperative that product labels encompass a comprehensive array of mandatory information, ensuring transparency and consumer awareness. Serving as a crucial link of communication, these labels elucidate essential details about the cosmetic product to the end user. Beyond mere formality, adhering to these label requirements reflects a commitment to […]

D4, D5 and D6: Substances of Very High Concern

D4, D5, D6

Back in November 9, 2023 the European Court of Justice, after a long legal battle against Global Silicones and others (the list is long: Dow Silicones UK Ltd, Evonik Operations GmbH, Shin-Etsu Silicones Europe BV, just to name a few) confirmed the classification of D4, D5 and D6 as substances of very high concern (SVHC), […]

Overview of the Toxicological Risk Assessment | Medical Devices

Toxicological Risk Assessment

The Regulation (EU) 2017/745 on medical devices is designed to establish a robust regulatory framework, ensuring a high standard of quality and safety for products. This comprehensive regulation addresses crucial aspects such as biocompatibility and the chemical and physical characterization of materials. These pivotal elements are also outlined in Annex I of the Regulation, focusing […]

Benzydamine and inflammatory pain – Molecular Pain

A new article was released in Molecular Pain magazine, in which our estimated colleague Giorgina Mangano is one of the authors! Benzydamine, an active pharmaceutical compound, was shown to have analgesic and anaesthetic properties after local applications. The chemical is generally used in oral care pharmaceutical preparations due to its anti-inflammatory actions, acting on pro-inflammatory […]

IUCLID latest update, 07.11.2023

ECHA has recently released a comprehensive IUCLID dataset comprising 528 approved pharmaceuticals, showcasing information gathered from both animal studies and human data. This addition to the dataset marks a significant step forward in supporting the development of alternatives to traditional animal testing. This update involves the inclusion of data on 180 new substances, complementing the […]